Furthermore, the ratio between CD14+HLA-DRhi pro-inflammatory cells and M-MDSCs was inversely correlated with the disease duration in PPMS, suggesting that the dampened immunoregulatory context might worsen the disease progression in these patients. This evidence concerns the gene CD14 and primary progressive multiple sclerosis.